Accueil>>Signaling Pathways>> Immunology/Inflammation>> NF-κB>>PTD-p65-P1 Peptide

PTD-p65-P1 Peptide

Catalog No.GC37036

Le peptide PTD-p65-P1 est un inhibiteur puissant et sélectif du facteur de transcription nucléaire NF-κB et dérive de la sous-unité p65 des résidus d'acides aminés NF-κB 271-282, qui inhibe sélectivement l'activation de NF-κB induite par diverses stimulations inflammatoires, régulent l'expression génique médiée par NF-κB et régulent À la hausse l'apoptose .

Products are for research use only. Not for human use. We do not sell to patients.

PTD-p65-P1 Peptide Chemical Structure

Taille Prix Stock Qté
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PTD-p65-P1 Peptide is a nuclear transcription factor NF-kappaB inhibitor, composed of a membrane-translocating peptide sequence generated from antennapedia (PTD) conjugated with p65-P1, which selectively inhibits activation induced by various inflammatory stimuli[1]. NF-kappaB[1]

[1]. Takada Y, et al. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis. J Biol Chem. 2004 Apr 9;279(15):15096-104.

Avis

Review for PTD-p65-P1 Peptide

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PTD-p65-P1 Peptide

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.